View online

Forward to a friend | Facebook | Twitter

Bioprocessing: Jan 31, 2024

Newsletter Sponsor

Do you know the Benefits and Applications of Trehalose Dihydrate?

Ashland has introduced Vialose™ trehalose dihydrate, a functional excipient that offers excellent protection and stabilization of proteins in injectable drugs. Vialose™ trehalose dihydrate is a result of Ashland's cutting-edge solutions that cater to the changing requirements of the sector. With Vialose™ trehalose dihydrate, drug manufacturers can effectively preserve and maintain the efficacy of protein-based drugs, which are known to be highly susceptible to degradation and instability.

	Industry News

FDA Grants Orphan Drug Designation (ODD) Status to Pancreatic Cancer Treatment
NeoImmuneTech, Inc. , a T cell-focused therapeutics company, announced that the FDA granted NT-I7 (... read more »

Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy
Teva announced its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI... read more »

Sandoz Launches First Biosimilar for Multiple Sclerosis, Tyruko®, in Germany
Sandoz announced the launch of Tyruko® (natalizumab) in Germany from February 1. Developed by ... read more »

	Featured Articles

		Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery Pharmaceutical formulation refers to the process in which different chemical ... read more »

		Pharmaceutical P.I.N. Points Patent Innovation News Nov/Dec 2023 The purpose of this column is to highlight and summarize recent key patents in ... read more »

	Infographic

API Reference Standard Selection
Important Considerations to meet ISO 17034 Accreditation
This infographic outlines essential information for drug developers when choosing a reference ... read more »

	Featured Products

Pearlitol 200GT
Barentz PEARLITOL® 200 GT mannitol is a direct compression excipient, specially designed to reduce capping ... learn more »

FlowLac® 90
Barentz The product FlowLac® is produced by spray-drying a suspension of fine milled alpha-lactose ... learn more »

DuraLac® H
Barentz DuraLac® H is produced by roller-drying a lactose solution at high temperature to form ... learn more »

	Featured Whitepaper

Guide: The Seven Most Asked Questions About Melting Point in the Pharmaceutical Industry
This guide from METTLER TOLEDO answers common questions related to the importance of melting point for pharmaceutical ingredients, the factors affecting melting point, USP requirements, and 21 CFR ... read more »

	More Products

PEARLITOL® ProTec Learn More
LYCATAB® C Learn More
ReadiLYCOAT® Learn More

	Directory Categories

Pharmaceutical Excipients Search More

Pharmaceutical Bioreactors and Fermentors Search More

Single Use Mixers / Single Use Mixing Systems Search More

	Events

INTERPHEX 2024
Javits Center, NYC – 04/16/2024
INTERPHEX returns to New York City on April 16-18, 2024. Register today and see for yourself why INTERPHEX is THE leading global event that takes you ... event details »

DCAT Week 2024
New York City – 03/18/2024
The Premiere Event for the Global Bio/Pharmaceutical Manufacturing Value Chain event details »

Ensure delivery to your inbox: Add newsletters@americanpharmaceuticalreview.com to your address book.

Follow American Pharmaceutical Review: Twitter | Facebook

This information is being brought to you because
you are a subscriber to American Pharmaceutical Review

Manage your Subscription | Unsubscribe | Contact Us